Atul D. Joshi

Employment

• Old Dominion University Research Scientist
  2013 - Present
• Georgia Regents University Senior Post-doctoral fellow
  2010 - 2013
• Georgia Regents University Senior Post-doctoral fellow
  2008 - 2010

Education

• University at Buffalo - The State University of New York Ph.D.
  1996 - 2003

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Novel Mechanism of Attenuation of LPS-Induced NF-κB Activation by the Heat Shock Protein 90 Inhibitor, 17-N-allylamino-17-demethoxygeldanamycin, in Human Lung Microvascular Endothelial Cells
  Am J Respir Cell Mol Biol 2014 DOI: 10.1165/rcmb.2013-0214oc
  +Save
• Hsp90 Inhibitors Prevent LPS-Induced Endothelial Barrier Dysfunction by Disrupting RhoA Signaling
  Am J Respir Cell Mol Biol 2013 DOI: 10.1165/rcmb.2012-0496oc
  +Save
• LPS induces pp60c-src-mediated tyrosine phosphorylation of Hsp90 in lung vascular endothelial cells and mouse lung
  AJP: Lung Cellular and Molecular Physiology 2013 DOI: 10.1152/ajplung.00419.2012
  +Save
• Heat Shock Protein 90 Inhibition Depletes TrkA Levels and Signaling in Human Acute Leukemia Cells
  Molecular Cancer Therapeutics 2010 DOI: 10.1158/1535-7163.mct-10-0336
  +Save
• Role of CAAT/Enhancer Binding Protein Homologous Protein in Panobinostat-Mediated Potentiation of Bortezomib-Induced Lethal Endoplasmic Reticulum Stress in Mantle Cell Lymphoma Cells
  Clinical Cancer Research 2010 DOI: 10.1158/1078-0432.ccr-10-0529
  +Save
• Treatment with Panobinostat Induces Glucose-Regulated Protein 78 Acetylation and Endoplasmic Reticulum Stress in Breast Cancer Cells
  Molecular Cancer Therapeutics 2010 DOI: 10.1158/1535-7163.mct-09-0988
  +Save
• Abstract 640: SIRT2 deacetylates peroxiredoxin and increases sensitivity to oxidative stress in human breast cancer cells
  Cancer Research 2010 DOI: 10.1158/1538-7445.am10-640
  +Save
• Abstract P3-04-03: Combined Epigenetic Targeting Reverses Epithelial-Mesencymal Transition (EMT) and Reduces Invasiveness of Human Breast Cancer Cells
  Cancer Research 2010 DOI: 10.1158/0008-5472.sabcs10-p3-04-03
  +Save
• Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells
  Blood 2009 DOI: 10.1182/blood-2009-05-222133
  +Save
• Co-treatment with heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and vorinostat: a highly active combination against human Mantle Cell Lymphoma (MCL) cells
  cbt 2009 DOI: 10.4161/cbt.8.13.8726
  +Save